Goodwin Biotechnology has appointed Gerald Orehostky as vice president, quality and regulatory. As a full GMP, FDA-registered and inspected biopharmaceuticals contract development and manufacturing organization (CDMO), Goodwin has continued its expansion to add commercial cGMP solutions to augment its offering of a fully integrated Single Source Solution from cell line development, process development including bioconjugation, scale-up, cGMP contract manufacturing and aseptic fill/finish of mamm...